Cargando…
Preponderance of CTLA4 Variation Associated With Autosomal Dominant Immune Dysregulation in the MYPPPY Motif
One of the primary targets of immune checkpoint inhibition is the negative immune regulatory molecule CTLA-4. Immune-related adverse events are commonly observed following CTLA-4 inhibition in melanoma treatment, and a spectrum of these conditions are also observed in individuals with germline haplo...
Autores principales: | Siggs, Owen M., Russell, Amanda, Singh-Grewal, Davinder, Wong, Melanie, Chan, Pearl, Craig, Maria E., O'Loughlin, Ted, Stormon, Michael, Goodnow, Christopher C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664875/ https://www.ncbi.nlm.nih.gov/pubmed/31396201 http://dx.doi.org/10.3389/fimmu.2019.01544 |
Ejemplares similares
-
Autosomal-dominant immune dysregulation syndrome in humans with CTLA4 mutations
por: Schubert, Desirée, et al.
Publicado: (2014) -
Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulation
por: Burnett, Deborah L, et al.
Publicado: (2017) -
Autosomal dominant nanophthalmos and high hyperopia associated with a C-terminal frameshift variant in MYRF
por: Siggs, Owen M., et al.
Publicado: (2019) -
Rural preponderance of testicular neoplasms.
por: Talerman, A., et al.
Publicado: (1974) -
La prépondérance anglaise (1715-1763)
por: Muret, Pierre
Publicado: (1949)